000 | 00991 a2200301 4500 | ||
---|---|---|---|
005 | 20250510210900.0 | ||
264 | 0 | _c19780223 | |
008 | 197802s 0 0 eng d | ||
022 | _a0033-6890 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSaba, T M | |
245 | 0 | 0 |
_aAlteration of tumor growth by a purified alpha-2-glycoprotein. _h[electronic resource] |
260 |
_bJournal of the Reticuloendothelial Society _cDec 1977 |
||
300 |
_a583-96 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAlpha-Globulins _xtherapeutic use |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCarcinoma 256, Walker _xdrug therapy |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aHeparin |
650 | 0 | 4 |
_aKupffer Cells _xphysiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aOpsonin Proteins |
650 | 0 | 4 | _aPhagocytosis |
650 | 0 | 4 | _aRats |
700 | 1 | _aCho, E | |
773 | 0 |
_tJournal of the Reticuloendothelial Society _gvol. 22 _gno. 6 _gp. 583-96 |
|
999 |
_c71697 _d71697 |